Prostate Ewing Sarcoma/PNET: A case of long survival in a highly aggressive malignancy

Prostate Ewing sarcoma/peripheral primitive neuroectodermal tumor (ES/PNET) is extremely rare. Currently, a multimodal approach is recommended, although there is no standard treatment. Nevertheless, this tumor has a very poor prognosis, with the longest reported survival of 24 months. We present a c...

Full description

Saved in:
Bibliographic Details
Published inUrology (Ridgewood, N.J.) Vol. 154; pp. e11 - e12
Main Authors Borges da Ponte, Carolina, Leitão, Tito Palmela, Miranda, Miguel, Polido, Joana, Alvim, Cecília, Fernandes, Isabel, Braga, Teresa, Pena, Bárbara, de Almeida, José Mendes, Costa, Luís, dos Reis, José Palma
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.08.2021
Subjects
Adult
Disease-Free Survival
Humans
Male
Prostatic Neoplasms - pathology
Prostatic Neoplasms - therapy
Sarcoma, Ewing - pathology
Sarcoma, Ewing - therapy
Time Factors
Online AccessGet full text

Cover

More Information
Summary:Prostate Ewing sarcoma/peripheral primitive neuroectodermal tumor (ES/PNET) is extremely rare. Currently, a multimodal approach is recommended, although there is no standard treatment. Nevertheless, this tumor has a very poor prognosis, with the longest reported survival of 24 months. We present a case of locally advanced prostate ES/PNET in a 29-year-old male who was treated with a multimodal approach. The patient is alive and disease free, with a seven year follow-up, with very good quality of life. This exceptionally long survival may be the result of the very aggressive multimodal treatment chosen and described herein.
Bibliography:ObjectType-Case Study-2
SourceType-Scholarly Journals-1
ObjectType-Feature-4
content type line 23
ObjectType-Report-1
ObjectType-Article-3
ISSN:0090-4295
1527-9995
DOI:10.1016/j.urology.2021.05.006